RT Conference Proceedings
T1 Resistance acquisition after seven cycles of in vitro bleomycin exposure
A1 Burgos-Molina, Antonio Manuel
A1 Gil-Carmona, Luisa
A1 Lumbreras-Vega, Luis Joaquín
A1 Ruiz-Gómez, Miguel José
K1 Medicina
AB Bleomycin is an antineoplastic drug that causes DNA damage by intra- and inter-strand crosslink and DNA strand breaks. This drug is used to treat several types of cancer.The aim of this work is to study the effect of Bleomycin on S. cerevisiae cells and select bleomycin-resistant cells to study the process of resistance acquisition to establish new protocols in in vitro drugs exposure.
YR 2019
FD 2019-01-16
LK https://hdl.handle.net/10630/17157
UL https://hdl.handle.net/10630/17157
LA eng
NO Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.
DS RIUMA. Repositorio Institucional de la Universidad de Málaga
RD 19 ene 2026